Until now, despite the extensive literature on DUBs, whether oncoproteins whose upregulation is required for cancer enhancement could affect DUBs remained unclear, which may in part likely reflect variation in DUB abundances in different tumour types. The gene discussed is ZUP1; the disease is cancer.